These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 29784667)

  • 1. Pattern-Specific Transcriptomics Identifies
    Tanaka H; Kanda M; Miwa T; Tanaka C; Kobayashi D; Umeda S; Shibata M; Suenaga M; Hattori N; Hayashi M; Iwata N; Yamada S; Nakayama G; Fujiwara M; Kodera Y
    Mol Cancer Res; 2018 Sep; 16(9):1420-1429. PubMed ID: 29784667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asialoglycoprotein Receptor 2 Expression in Patients With Locally Advanced Gastric Cancer After Curative Resection.
    Oshima T; Hashimoto I; Hiroshima Y; Kimura Y; Tanabe M; Onuma S; Nagasawa S; Kanematsu K; Aoyama T; Yamada T; Ogata T; Rino Y; Saito A; Miyagi Y
    Anticancer Res; 2024 Jan; 44(1):397-402. PubMed ID: 38159992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of SYT8 For the Detection, Prediction, and Treatment of Peritoneal Metastasis From Gastric Cancer.
    Kanda M; Shimizu D; Tanaka H; Tanaka C; Kobayashi D; Hayashi M; Iwata N; Niwa Y; Yamada S; Fujii T; Sugimoto H; Murotani K; Fujiwara M; Kodera Y
    Ann Surg; 2018 Mar; 267(3):495-503. PubMed ID: 28026832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced ASGR2 by microplastic exposure leads to resistance to therapy in gastric cancer.
    Kim H; Zaheer J; Choi EJ; Kim JS
    Theranostics; 2022; 12(7):3217-3236. PubMed ID: 35547772
    [No Abstract]   [Full Text] [Related]  

  • 5. GPR155 Serves as a Predictive Biomarker for Hematogenous Metastasis in Patients with Gastric Cancer.
    Shimizu D; Kanda M; Tanaka H; Kobayashi D; Tanaka C; Hayashi M; Iwata N; Niwa Y; Takami H; Yamada S; Fujii T; Nakayama G; Fujiwara M; Kodera Y
    Sci Rep; 2017 Feb; 7():42089. PubMed ID: 28165032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of sushi domain containing two reflects the malignant potential of gastric cancer.
    Umeda S; Kanda M; Miwa T; Tanaka H; Tanaka C; Kobayashi D; Suenaga M; Hattori N; Hayashi M; Yamada S; Nakayama G; Fujiwara M; Kodera Y
    Cancer Med; 2018 Oct; 7(10):5194-5204. PubMed ID: 30259711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Troponin I2 as a Specific Biomarker for Prediction of Peritoneal Metastasis in Gastric Cancer.
    Sawaki K; Kanda M; Miwa T; Umeda S; Tanaka H; Tanaka C; Kobayashi D; Suenaga M; Hattori N; Hayashi M; Yamada S; Nakayama G; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2018 Jul; 25(7):2083-2090. PubMed ID: 29663169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FAM46C Serves as a Predictor of Hepatic Recurrence in Patients with Resectable Gastric Cancer.
    Tanaka H; Kanda M; Shimizu D; Tanaka C; Kobayashi D; Hayashi M; Iwata N; Yamada S; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Niwa Y; Kodera Y
    Ann Surg Oncol; 2017 Oct; 24(11):3438-3445. PubMed ID: 27770343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
    Guo J; Zu G; Zhou T; Xing J; Wang Z
    Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DC - SIGNR by influencing the lncRNA HNRNPKP2 upregulates the expression of CXCR4 in gastric cancer liver metastasis.
    Zhang Y; Zhang Q; Zhang M; Yuan M; Wang Z; Zhang J; Zhou X; Zhang Y; Lin F; Na H; Ren S; Zuo Y
    Mol Cancer; 2017 Apr; 16(1):78. PubMed ID: 28403883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptomic profiling on localized gastric cancer identified CPLX1 as a gene promoting malignant phenotype of gastric cancer and a predictor of recurrence after surgery and subsequent chemotherapy.
    Tanaka H; Kanda M; Shimizu D; Tanaka C; Inokawa Y; Hattori N; Hayashi M; Nakayama G; Kodera Y
    J Gastroenterol; 2022 Sep; 57(9):640-653. PubMed ID: 35726075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival times are similar among patients with peritoneal, hematogenous, and nodal recurrences after curative resections for gastric cancer.
    Sawaki K; Kanda M; Ito S; Mochizuki Y; Teramoto H; Ishigure K; Murai T; Asada T; Ishiyama A; Matsushita H; Tanaka C; Kobayashi D; Fujiwara M; Murotani K; Kodera Y
    Cancer Med; 2020 Aug; 9(15):5392-5399. PubMed ID: 32515147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synaptotagmin XIII expression and peritoneal metastasis in gastric cancer.
    Kanda M; Shimizu D; Tanaka H; Tanaka C; Kobayashi D; Hayashi M; Takami H; Niwa Y; Yamada S; Fujii T; Sugimoto H; Kodera Y
    Br J Surg; 2018 Sep; 105(10):1349-1358. PubMed ID: 29741294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Consequences of Mannose and Asialoglycoprotein Receptor Ablation.
    Mi Y; Coonce M; Fiete D; Steirer L; Dveksler G; Townsend RR; Baenziger JU
    J Biol Chem; 2016 Sep; 291(36):18700-17. PubMed ID: 27405760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic suppression of the immunoregulator MZB1 is associated with the malignant phenotype of gastric cancer.
    Kanda M; Tanaka C; Kobayashi D; Tanaka H; Shimizu D; Shibata M; Takami H; Hayashi M; Iwata N; Niwa Y; Yamada S; Fujii T; Nakayama G; Fujiwara M; Kodera Y
    Int J Cancer; 2016 Nov; 139(10):2290-8. PubMed ID: 27459504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancer.
    Kanda M; Shimizu D; Tanaka H; Shibata M; Iwata N; Hayashi M; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Oncotarget; 2016 Mar; 7(12):13667-79. PubMed ID: 26872374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Noncoding RNA GMAN, Up-regulated in Gastric Cancer Tissues, Is Associated With Metastasis in Patients and Promotes Translation of Ephrin A1 by Competitively Binding GMAN-AS.
    Zhuo W; Liu Y; Li S; Guo D; Sun Q; Jin J; Rao X; Li M; Sun M; Jiang M; Xu Y; Teng L; Jin Y; Si J; Liu W; Kang Y; Zhou T
    Gastroenterology; 2019 Feb; 156(3):676-691.e11. PubMed ID: 30445010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of the recurrence pattern and risk factors for recurrence in patients with proximal gastric cancer who underwent curative gastrectomy.
    Bilici A; Selcukbiricik F
    Tumour Biol; 2015 Aug; 36(8):6191-9. PubMed ID: 25761877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium Channel Subunit SCNN1B Suppresses Gastric Cancer Growth and Metastasis via GRP78 Degradation.
    Qian Y; Wong CC; Xu J; Chen H; Zhang Y; Kang W; Wang H; Zhang L; Li W; Chu ESH; Go MYY; Chiu PWY; Ng EKW; Chan FKL; Sung JJY; Si J; Yu J
    Cancer Res; 2017 Apr; 77(8):1968-1982. PubMed ID: 28202509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Discoidin Domain Receptor 1 Prevents Stroma-Induced Peritoneal Metastasis in Gastric Carcinoma.
    Jin H; Ham IH; Oh HJ; Bae CA; Lee D; Kim YB; Son SY; Chwae YJ; Han SU; Brekken RA; Hur H
    Mol Cancer Res; 2018 Oct; 16(10):1590-1600. PubMed ID: 29866925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.